Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. | Director | Nonstatutory Stock Option (right to buy) | 50.6K | May 29, 2024 | Direct | ||
CytomX Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38K | May 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KPTI | Karyopharm Therapeutics Inc. | May 29, 2024 | 1 | $0 | 4 | May 30, 2024 | Director |
CTMX | CytomX Therapeutics, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
CTMX | CytomX Therapeutics, Inc. | Mar 20, 2024 | 1 | $0 | 4 | Mar 22, 2024 | Director |
CTMX | CytomX Therapeutics, Inc. | Mar 20, 2024 | 0 | $0 | 3 | Mar 22, 2024 | Director |
KPTI | Karyopharm Therapeutics Inc. | Aug 31, 2023 | 1 | $0 | 4 | Sep 1, 2023 | Director |
KPTI | Karyopharm Therapeutics Inc. | Aug 31, 2023 | 0 | $0 | 3 | Sep 1, 2023 | Director |